Artificial intelligence, a new ally against leukaemia

M. Carolina Florian

  • PROJECT LEADER

    M. Carolina Florian

  • HOST ORGANIZATION, COUNTRY

    Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Spain

  • DESCRIPTION

    People over 60 with acute myeloid leukaemia (AML) who receive chemotherapy have a very low survival rate of up to nine months from diagnosis. Therefore, new treatments are needed for these tumours.

    In this context, artificial intelligence may be an ally when analysing complex databases to find new ways of interpreting data and arriving at new and novel therapeutic strategies.

    This project sets out to develop a new strategy, based on deep learning algorithms to understand how tumour cells interact with old bone marrow and its environment. This knowledge will enable the definition of new therapeutic targets to halt tumour growth.

  • CONSORTIUM
    (PRINCIPAL INVESTIGATOR, ORGANIZATION, COUNTRY)

    Medhanie Mulaw, Universität Ulm, Alemania

  • PROJECT TITLE

    Deep learning to dissect the interaction between leukemic cells and the ageing niche (DeepAgeNiche)

  • BUDGET

    817.046 €